{"companyId":277508,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"BioLineRx Ltd.","headOfficeLocation":"Modi'in, Israel","presidentName":"Philip A. Serlin","companySummary":null,"stockCode":"BLRX","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["biolinerx.com"],"businessContents":["Clinical-stage biopharmaceutical drug development","Oncology and rare disease therapeutics licensing"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://biolinerx.com/about/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}